The surge in positive cases have summoned clinical communities to the front lines of the pandemic. And while governments—state and federal—have ordered residents to shelter-in-place, to social distance or self-quarantine, the scientific community has mobilized and converged its diverse areas of expertise to problem-solve a cure for the virus in real time.
Now in its second year, Crain’s Notable Women in Health Care celebrates an industry uniquely shaped by women.
Twenty years ago, Katie Couric’s on-air colonoscopy on the Today Show inspired so many people to get checked. Doctors termed it “The Couric Effect”, which later helped to inspire Stand Up To Cancer (SU2C), raising hundreds of millions of dollars.
The longtime Cleveland starter received a diagnosis of chronic myeloid leukemia last spring, then spent much of his recovery time helping others.
Douglas Rozen is Chief Media Officer at 360i, as well as a colorectal cancer survivor, avid cyclist and Stand Up To Cancer (SU2C) ambassador.
Lack of access and mistrust often keep diverse patients from participating in clinical trials. Nonprofit group Stand Up To Cancer wants to change that.
Stand Up To Cancer has launched two initiatives to increase minority representation in cancer clinical trials by amending its grant application requirements and funding a new research team focused on diversity and inclusion.
Cancer research is rapidly advancing and mortality from the disease is dropping, but not all patients are benefiting equally.
Dr. Edith Perez, a Mayo Clinic oncologist and chair of the Stand Up To Cancer committee for health equity in cancer clinical trials today announced a new Stand Up To Cancer Health Equity Initiative aimed at reducing disparities among racial groups in cancer clinical trials.
